JSON
Chen Q, Zhao B, Tan Z, Hedberg G, Wang J, Gonzalez L, Mugabo CH, Johnsson A, Negrini E, Páez LP, Rodriguez L, James A, Chen Y, Mikeš J, Bernhardsson AK, Reitzner SM, von Walden F, O'Neill O, Barcenilla H, Wang C, Davis MM, Carlson LM, Pal N, Blomgren K, Repsilber D, Herold N, Lakshmikanth T, Kogner P, Ljungblad L, Brodin P
Cell - (-) - [2025-01-17; online 2025-01-17]
Cancer is the leading cause of death from disease in children. Survival depends not only on surgery, cytostatic drugs, and radiation but also on systemic immune responses. Factors influencing these immune responses in children of different ages and tumor types are unknown. Novel immunotherapies can enhance anti-tumor immune responses, but few children have benefited, and markers of effective responses are lacking. Here, we present a systems-level analysis of immune responses in 191 children within a population-based cohort with diverse tumors and reveal that age and tumor type shape immune responses differently. Systemic inflammation and cytotoxic T cell responses correlate with tumor mutation rates and immune cell infiltration. Clonally expanded T cell responses are rarely detected in blood or tumors at diagnosis but are sometimes elicited during treatment. Expanded T cells are similarly regulated in children and adults with more immunogenic cancers. This research aims to facilitate the development of precision immunotherapies for children with cancer.
NGI Stockholm (Genomics Production) [Service]
National Genomics Infrastructure [Service]
PubMed 39837329
DOI 10.1016/j.cell.2024.12.014
Crossref 10.1016/j.cell.2024.12.014
pii: S0092-8674(24)01427-2